ロード中...
Efficacy and safety of alirocumab in Korean patients with hypercholesterolemia and high cardiovascular risk: subanalysis of the ODYSSEY-KT study
BACKGROUND/AIMS: Efficacy and safety data of alirocumab, a fully human monoclonal antibody to proprotein convertase subtilisin/kexin type 9 (PCSK9), is not yet well established in the Korean population. We assessed them in ODYSSEY-KT through the pre-specified Korean subanalysis. METHODS: In the ODYS...
保存先:
| 出版年: | Korean J Intern Med |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Korean Association of Internal Medicine
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6823573/ https://ncbi.nlm.nih.gov/pubmed/30257549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2018.133 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|